GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM39443
Query DataSets for GSM39443
Status
Public on Apr 01, 2005
Title
ms53-4
Sample type
RNA
Source name
Staged C. elegans embryos
Organism
Caenorhabditis elegans
Extracted molecule
total RNA
Description
Mutant genotype mex-3(zu155); skn-1(RNAi) 53 minutes after the 4-cell embryonic stage at 22 degrees C
Sample_genotype: ms
Sample_time: 53
Submission date
Jan 24, 2005
Last update date
May 27, 2005
Contact name
Andrew Hill
E-mail(s)
andrew.hill@pfizer.com
Phone
617-674-6341
Organization name
Pfizer
Department
Research Business Technology
Street address
300 Technology Square
City
Cambridge
State/province
MA
ZIP/Postal code
02139
Country
USA
Platform ID
GPL200
Series (1)
GSE2180
C. elegans embryonic timecourse in wt and mutant embryos
Data table header descriptions
ID_REF
Affymetrix Qualifier
VALUE
RMA calulated using Bioconductor Affy package (http://www.bioconductor.org)
Data table
ID_REF
VALUE
171720_x_at
4.97220837558364
171721_x_at
5.2889156030193
171722_x_at
4.86555878911821
171723_x_at
3.47211800560690
171724_x_at
6.07931425747237
171725_x_at
4.18536432729144
171726_x_at
5.03366925846927
171727_x_at
2.82299220209955
171728_x_at
2.97869348078798
171729_x_at
6.0102196468453
171730_x_at
2.65950979112253
171731_x_at
8.10591576885527
171732_x_at
6.04531280817599
171733_x_at
3.70518899219613
171734_x_at
9.88800113262914
171735_x_at
3.11788659291172
171736_x_at
7.27939209409019
171737_x_at
5.41735798020787
171738_x_at
5.08421609531598
171739_x_at
3.37729064606579
Total number of rows:
22625
Table truncated, full table size
608 Kbytes
.
Supplementary file
Size
Download
File type/resource
GSM39443.CEL.gz
2.7 Mb
(ftp)
(http)
CEL
GSM39443.EXP.gz
328 b
(ftp)
(http)
EXP
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|
